Zhejiang Crystal-Optech's P/E is lower than the market despite forecast growth aligning with the wider market, suggesting shareholders doubt the forecasts and accept lower selling prices. Unobserved threats to earnings may prevent the P/E ratio from matching the outlook.
Gushengtang Holdings' growth could be driven by factors like high earnings retention or proficient management, despite a slightly low ROE. Its positive business aspects and high reinvestment rate possibly contribute to significant earnings growth.
The rise in Gushengtang's ROCE bodes well for its capital reinvestment prowess. While the stock only returned 6.5% to shareholders in the past year, investors may not fully grasp the promising fundamentals, suggesting further stock research is needed.
Key points: 1. Hang Seng Index fell 2.57% in the first two weeks (2023/05/22 to 2023/06/02), with all 12 Hang Seng industries falling. Among them, the Hang Seng healthcare sector fell 1.51%, outperforming the Hang Seng Index by 1.06 percentage points, ranking third among the 12 Hang Seng industries 2. On May 22, the results of the f...
GUSHENGTANGに関するコメント
1. Hang Seng Index fell 2.57% in the first two weeks (2023/05/22 to 2023/06/02), with all 12 Hang Seng industries falling. Among them, the Hang Seng healthcare sector fell 1.51%, outperforming the Hang Seng Index by 1.06 percentage points, ranking third among the 12 Hang Seng industries
2. On May 22, the results of the f...
まだコメントはありません